• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    S&P 500 Edges Lower; RH Shares Plunge After Q1 Results

    6/14/24 3:36:13 PM ET
    $FOXO
    $GANX
    $IRON
    $QXO
    Life Insurance
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $FOXO alert in real time by email

    U.S. stocks traded mixed toward the trading, with the Dow Jones index falling around 0.2% on Friday.

    The Dow traded down 0.24% to 38,554.69 while the NASDAQ rose 0.07% to 17,680.01. The S&P 500 also fell, dropping, 0.10% to 5,428.33.                                                                                             .

    Check This Out: Top 2 Materials Stocks That May Collapse This Quarter

    Leading and Lagging Sectors

    Communication services shares jumped by 0.5% on Friday.

    In trading on Friday, industrials shares fell by 1.2%.

    Top Headline

    The total number of active U.S. oil rigs declined by four to 488 rigs this week, Baker Hughes Inc reported.

    Equities Trading UP
                           

    • Disc Medicine, Inc. (NASDAQ:IRON) shares shot up 19% to $46.63. The company announced the presentation of data at the European Hematology Association 2024 Congress and announced an underwritten offering.
    • Shares of SRIVARU Holding Limited (NASDAQ:SVMH) got a boost, surging 51% to $0.2305 after the company announced it will begin accepting paid reservations and bookings for its flagship product, the PRANA 2.0, on June 16th.
    • FOXO Technologies Inc. (NASDAQ:FOXO) shares were also up, gaining 17% to $0.2794 after the company announced it entered into share exchange agreements with Rennova Health.

    Equities Trading DOWN

    • QXO, Inc. (NASDAQ:QXO) shares dropped 32% to $140.57 after announcing a $3.5 billion private placement.
    • Shares of RH (NYSE:RH) were down 18% to $227.14 after the company reported mixed first-quarter financial results.
    • Gain Therapeutics, Inc. (NASDAQ:GANX) was down, falling 33% to $1.27 after the company announced the pricing of a $11 million public offering of 7,116,547 shares at $1.35 per share and pre-funded warrants.

    Also Check This Out: How To Earn $500 A Month From KB Home Stock Ahead Of Q2 Earnings

    Commodities

    In commodity news, oil traded up 0.1% to $78.64 while gold traded up 1.3% at $2,349.00.

    Silver traded up 1.9% to $29.605 on Friday, while copper rose 0.5% to $4.5015.

    Euro zone

    European shares were lower today. The eurozone's STOXX 600 fell 0.97%, Germany's DAX dipped 1.44% and France's CAC 40 tumbled 2.66%. Spain's IBEX 35 Index fell 0.67%, while London's FTSE 100 slipped 0.21%.

    The Eurozone recorded a trade surplus of EUR 15 billion in April versus a year-ago gap of EUR 11.1 billion. The annual inflation rate in France accelerated to 2.3% in May from 2.2% in April.

    Asia Pacific Markets

    Asian markets closed mostly higher on Friday, with Japan's Nikkei gaining 0.24%, Hong Kong's Hang Seng Index declining 0.94%, China's Shanghai Composite Index gaining 0.12% and India's S&P BSE Sensex gaining 0.24%.

    Indian merchandise trade deficit widened to a seven-month of $23.8 billion in May, while wholesale prices increased by 2.61% year-over-year in May. Manufacturing production in Hong Kong increased 1.8% year-over-year in the first quarter versus a 4.1% rise in the prior period. Chinese vehicle sales gained by 1.5% year-over-year to 2.42 million in May.

    Industrial production in Japan fell 0.9% month-over-month in April. The Bank of Japan held its key short-term interest rate at about 0% to 0.1% at its recent meeting.

    Economics

    • Import prices in the U.S. declined by 0.4% month-over-month in May.
    • U.S. export prices declined by 0.6% month-over-month in May compared to a revised 0.6% gain in the prior month.
    • The University of Michigan consumer sentiment declined for a third consecutive month to a reading of 65.6 in June, notching the lowest level since November, compared to 69.1 in May and down from market estimates of 72.
    • The total number of active U.S. oil rigs declined by four to 488 rigs this week, Baker Hughes Inc reported.

    Now Read This: Hasbro To Rally Around 38%? Here Are 10 Top Analyst Forecasts For Friday

    Get the next $FOXO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FOXO
    $GANX
    $IRON
    $QXO

    CompanyDatePrice TargetRatingAnalyst
    QXO Inc.
    $QXO
    12/12/2025$31.00Buy
    Loop Capital
    RH
    $RH
    12/12/2025$165.00Buy → Hold
    Stifel
    RH
    $RH
    12/12/2025$220.00 → $185.00Market Perform
    Telsey Advisory Group
    Disc Medicine Inc.
    $IRON
    11/3/2025$125.00Buy
    Stifel
    QXO Inc.
    $QXO
    10/21/2025$30.00Buy
    Vertical Research
    RH
    $RH
    10/2/2025Outperform → Mkt Perform
    William Blair
    QXO Inc.
    $QXO
    10/1/2025$28.00Overweight
    KeyBanc Capital Markets
    RH
    $RH
    9/12/2025$220.00Outperform → Market Perform
    Telsey Advisory Group
    More analyst ratings

    $FOXO
    $GANX
    $IRON
    $QXO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Franchi Jean M. sold $719,727 worth of shares (11,156 units at $64.51), decreasing direct ownership by 14% to 71,343 units (SEC Form 4)

    4 - Disc Medicine, Inc. (0001816736) (Issuer)

    2/19/26 5:42:56 PM ET
    $IRON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Legal Officer Khara Rahul sold $179,340 worth of shares (2,853 units at $62.86), decreasing direct ownership by 5% to 52,173 units (SEC Form 4)

    4 - Disc Medicine, Inc. (0001816736) (Issuer)

    2/17/26 9:20:07 PM ET
    $IRON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Commercial Officer Stephenson Pamela sold $347,679 worth of shares (5,531 units at $62.86), decreasing direct ownership by 6% to 80,998 units (SEC Form 4)

    4 - Disc Medicine, Inc. (0001816736) (Issuer)

    2/17/26 9:15:38 PM ET
    $IRON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FOXO
    $GANX
    $IRON
    $QXO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CFO and Interim CEO Mack Gene bought $14,544 worth of shares (14,400 units at $1.01) (SEC Form 4)

    4 - Gain Therapeutics, Inc. (0001819411) (Issuer)

    8/12/24 5:23:31 PM ET
    $GANX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Executive Chairman Islam Khalid bought $49,940 worth of shares (50,000 units at $1.00) (SEC Form 4)

    4 - Gain Therapeutics, Inc. (0001819411) (Issuer)

    8/12/24 5:23:30 PM ET
    $GANX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Richman Eric I bought $20,670 worth of shares (17,000 units at $1.22), increasing direct ownership by 6% to 289,629 units (SEC Form 4)

    4 - Gain Therapeutics, Inc. (0001819411) (Issuer)

    7/1/24 5:00:27 PM ET
    $GANX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FOXO
    $GANX
    $IRON
    $QXO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Disc Medicine to Participate in Upcoming Investor Conferences

    WATERTOWN, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will present at two upcoming investor conferences: TD Cowen 46th Annual Health Care Conference on Tuesday, March 3rd at 9:50 a.m. ET in Boston, MA.Leerink Global Healthcare Conference on Monday, March 9th at 3:40 p.m. ET in Miami, FL. Disc management will be participating in investor meetings during the above conferences, as well as the Jefferies Biotech on the Beach Summit on March 1

    2/24/26 8:30:00 AM ET
    $IRON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    RH UNVEILS 2026 INTERIORS SPRING SOURCEBOOK

    RH (NYSE:RH) announced today the release of the 2026 RH Interiors Spring Sourcebook, presenting nearly 600 pages of inspired design by internationally renowned designers, artisans and manufacturers. From monastic minimalism to interstellar illumination, the rhythm of reeding to a study in stone, the comprehensive design resource represents the brand's continued commitment to imagination, innovation and quality. To view the full announcement, please click here. ABOUT RH RH (NYSE:RH) is a global curator of design, taste and style in the luxury lifestyle market. Operating across the United States, Canada, the United Kingdom and Europe, the Company offers collections through its retail ga

    2/23/26 9:05:00 AM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary

    Gain Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference

    BETHESDA, Md., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (NASDAQ:GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that the Company's management team will participate in a fireside chat and one-on-one meetings at the Oppenheimer 36th Annual Healthcare Life Sciences Conference, being held Wednesday, February 25th through Thursday, February 26th. Fireside Chat Details Date: Wednesday, February 25, 2026 Time: 1:20 p.m. ET To access a replay of the fireside chat visit here or the "Investors & Media/News & Events" section of the Company'

    2/19/26 7:00:00 AM ET
    $GANX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FOXO
    $GANX
    $IRON
    $QXO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

    Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/13/2021. Application Category: ANDA, Application Number: 213111, Application Classification:

    1/18/21 5:24:40 AM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary

    FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

    Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE ; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/13/2021. Application Category: ANDA, Application Number: 213111, Application Classification:

    1/18/21 5:24:40 AM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary

    FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

    Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE ; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/15/2021. Application Category: ANDA, Application Number: 213111, Application Classification:

    1/15/21 11:16:15 AM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary

    $FOXO
    $GANX
    $IRON
    $QXO
    SEC Filings

    View All

    SEC Form 144 filed by Disc Medicine Inc.

    144 - Disc Medicine, Inc. (0001816736) (Subject)

    2/18/26 4:41:31 PM ET
    $IRON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 144 filed by Disc Medicine Inc.

    144 - Disc Medicine, Inc. (0001816736) (Subject)

    2/17/26 8:54:47 PM ET
    $IRON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 144 filed by Disc Medicine Inc.

    144 - Disc Medicine, Inc. (0001816736) (Subject)

    2/17/26 8:43:01 PM ET
    $IRON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FOXO
    $GANX
    $IRON
    $QXO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Loop Capital initiated coverage on QXO, Inc with a new price target

    Loop Capital initiated coverage of QXO, Inc with a rating of Buy and set a new price target of $31.00

    12/12/25 8:55:06 AM ET
    $QXO
    RETAIL: Building Materials
    Consumer Discretionary

    RH downgraded by Stifel with a new price target

    Stifel downgraded RH from Buy to Hold and set a new price target of $165.00

    12/12/25 8:43:14 AM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary

    Telsey Advisory Group reiterated coverage on RH with a new price target

    Telsey Advisory Group reiterated coverage of RH with a rating of Market Perform and set a new price target of $185.00 from $220.00 previously

    12/12/25 8:16:25 AM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary

    $FOXO
    $GANX
    $IRON
    $QXO
    Financials

    Live finance-specific insights

    View All

    QXO Announces Fourth Quarter Summarized Preliminary Financial Information

    QXO, Inc. ("QXO" or the "Company") (NYSE:QXO) today announced the following summarized preliminary financial information. The Company expects to file its annual report on Form 10-K for the year ended December 31, 2025 on February 26, 2026. FOURTH QUARTER 2025 SUMMARY PRELIMINARY RESULTS Net sales of approximately $2.19 billion Adjusted EBITDA of approximately $150 million The Company's preliminary unaudited financial results in this press release for the fourth quarter ended December 31, 2025 are preliminary, unaudited and subject to completion, and may change as a result of management's continued review. Such preliminary results are subject to the finalization of quarter-end fin

    1/15/26 5:06:00 PM ET
    $QXO
    RETAIL: Building Materials
    Consumer Discretionary

    FOXO TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES YEAR-END REVIEW TO SHAREHOLDERS

    WEST PALM BEACH, FL, Dec. 15, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC:FOXO) (the "Company"), announces Chief Executive Officer Seamus Lagan has provided the following Year-End Review to shareholders: FOXO Shareholders: As we rapidly approach year-end, I wanted to reach out to our shareholders to review key milestones of 2025 and preview our go-forward operating and growth strategy. Much of the foundation of the "new" FOXO was created in mid-2024 when the Company acquired both Myrtle Recovery Centers, Inc. and Rennova Community Health, Inc. (including its principal subsidiary, Scott County Community Hospital, Inc.). More recently, we expanded our portfolio of healthcare-relat

    12/15/25 8:07:00 AM ET
    $FOXO
    Life Insurance
    Finance

    RH Reports Third Quarter Fiscal 2025 Results

    RH (NYSE:RH) has released its financial results for the third quarter ended November 1, 2025, in a shareholder letter from Chairman and Chief Executive Officer Gary Friedman, available on the Investor Relations section of its website at ir.rh.com. As previously announced, RH leadership will host a live conference call and audio webcast at 2:00 pm Pacific Time (5:00 pm Eastern Time) today. The live conference call may be accessed by dialing 800.715.9871 or 646.307.1963 for international callers (conference ID: 8284432). The call and replay can also be accessed via audio webcast at ir.rh.com. ABOUT RH RH (NYSE:RH) is a global curator of design, taste and style in the luxury lifestyle marke

    12/11/25 4:46:00 PM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary

    $FOXO
    $GANX
    $IRON
    $QXO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Disc Medicine Inc.

    SC 13G/A - Disc Medicine, Inc. (0001816736) (Subject)

    11/14/24 5:44:55 PM ET
    $IRON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by RH

    SC 13G/A - RH (0001528849) (Subject)

    11/14/24 5:05:51 PM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Disc Medicine Inc.

    SC 13G/A - Disc Medicine, Inc. (0001816736) (Subject)

    11/14/24 4:33:10 PM ET
    $IRON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FOXO
    $GANX
    $IRON
    $QXO
    Leadership Updates

    Live Leadership Updates

    View All

    Disc Medicine Appoints Lisa Amaya Price, MBA as Chief Human Resources Officer

    WATERTOWN, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the appointment of Lisa Amaya Price, MBA as the company's Chief Human Resources (HR) Officer. Ms. Amaya Price brings more than 25 years of experience in human resources and organizational leadership, including at multiple commercial-stage companies. "As we move towards commercialization, we have meaningfully increased hiring to support these efforts and Lisa will play a central role in building a strong, scal

    1/12/26 4:30:00 PM ET
    $IRON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FOXO TECHNOLOGIES INC.'S BIG SOUTH FORK MEDICAL CENTER COMPLETES PERFORMANCE NETWORK AGREEMENT WITH COVENANT HEALTH TO PROVIDE SWING BED SERVICES

    WEST PALM BEACH, FLORIDA, Aug. 01, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company") today announced that its critical access designated rural hospital, Big South Fork Medical Center located in Oneida, Tennessee, has completed a Performance Network Agreement with Covenant Health to join their performance network as a provider of swing bed services. Covenant Health is a large, muti-facility hospital network serving greater Knoxville and East Tennessee. Patients who no longer meet acute care admission criteria are frequently in need of post-acute care to enhance their recovery. Big South Fork Medical Center is well positioned to provide swing bed services

    8/1/25 7:52:00 AM ET
    $FOXO
    Life Insurance
    Finance

    QXO Appoints Michael DeWitt as Chief Procurement Officer

    QXO, Inc. (NYSE:QXO) today announced that Michael DeWitt has been appointed chief procurement officer, effective immediately. DeWitt will lead the company's procurement transformation as QXO scales to become the tech-enabled leader in the $800 billion building products distribution industry. DeWitt joins QXO after eight years as vice president of international spend management at Walmart International, where he was responsible for $10 billion of purchasing and digital transformation across 18 countries. He brings nearly three decades of experience in procurement innovation across multiple industries and continents. Brad Jacobs, chairman and chief executive officer of QXO, said, "Michael

    7/21/25 8:00:00 AM ET
    $QXO
    RETAIL: Building Materials
    Consumer Discretionary